ArticleHemaSphere2023

Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001.

Luca L G Janssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.